Supplementary Figure 1 from Mir200c Attenuates P-gp–Mediated MDR and Metastasis by Targeting JNK2/c-Jun Signaling Pathway in Colorectal Cancer

Hua Sui,Guo-Xiang Cai,Shu-Fang Pan,Wan-Li Deng,Yu-Wei Wang,Zhe-Sheng Chen,San-Jun Cai,Hui-Rong Zhu,Qi Li

DOI: https://doi.org/10.1158/1535-7163.22501866.v1

2023-01-01

Abstract:Supplementary Figure 1: miRNAs in the parental cells with those of MDR cells in colorectal cancer using miRNA microarray.

What problem does this paper attempt to address?

Supplementary Figure 3 from Mir200c Attenuates P-gp–Mediated MDR and Metastasis by Targeting JNK2/c-Jun Signaling Pathway in Colorectal Cancer

Hua Su,Guo-Xiang Cai,Shu-Fang Pan,Wanli Deng,Yuwei Wang,Zhe‐Sheng Chen,Sanjun Cai,Hong-Jian Zhu,Qi Li

DOI: https://doi.org/10.1158/1535-7163.22501860.v1

2023-01-01

Abstract:Supplementary Figure 3: Supplementary data for Figure 3 of the manuscript.
Data from Mir200c Attenuates P-gp–Mediated MDR and Metastasis by Targeting JNK2/c-Jun Signaling Pathway in Colorectal Cancer

Hua Sui,Guo-Xiang Cai,Shu-Fang Pan,Wan-Li Deng,Yu-Wei Wang,Zhe-Sheng Chen,San-Jun Cai,Hui-Rong Zhu,Qi Li

DOI: https://doi.org/10.1158/1535-7163.mct-14-0167

2014-01-01

Molecular Cancer Therapeutics

Abstract:Abstract MicroRNA-200c (miR200c) recently emerged as an important regulator of tumorigenicity and cancer metastasis; however, its role in regulating multidrug resistance (MDR) remains unknown. In the current study, we found that the expression levels of miR200c in recurrent and metastatic colorectal cancers were significantly lower, whereas the JNK2 expression was higher compared with primary tumors. We showed that in MDR colorectal cancer cells, miR200c targeted the 3′ untranslated region of the JNK2 gene. Overexpression of miR200c attenuated the levels of p-JNK, p-c-Jun, P-gp, and MMP-2/-9, the downstream factors of the JNK signaling pathway, resulting in increased sensitivity to chemotherapeutic drugs, which was accompanied by heightened apoptosis and decreased cell invasion and migration. Moreover, in an orthotopic MDR colorectal cancer mouse model, we demonstrated that overexpression of miR200c effectively inhibited the tumor growth and metastasis. At last, in the tumor samples from patients with locally advanced colorectal cancer with routine postsurgical chemotherapy, we observed an inverse correlation between the levels of mRNA expression of miR200c and JNK2, ABCB1, and MMP-9, thus predicting patient therapeutic outcomes. In summary, we found that miR200c negatively regulated the expression of JNK2 gene and increased the sensitivity of MDR colorectal cancer cells to chemotherapeutic drugs, via inhibiting the JNK2/p-JNK/p-c-Jun/ABCB1 signaling. Restoration of miR200c expression in MDR colorectal cancer may serve as a promising therapeutic approach in MDR-induced metastasis. Mol Cancer Ther; 13(12); 3137–51. ©2014 AACR.
Supplementary Materials and Methods and Supplementary Figure Legends from Mir200c Attenuates P-gp–Mediated MDR and Metastasis by Targeting JNK2/c-Jun Signaling Pathway in Colorectal Cancer

Hua Sui,Guo-Xiang Cai,Shu-Fang Pan,Wan-Li Deng,Yu-Wei Wang,Zhe-Sheng Chen,San-Jun Cai,Hui-Rong Zhu,Qi Li

DOI: https://doi.org/10.1158/1535-7163.22501854.v1

2023-01-01

Abstract:Supplementary Materials and Methods and Figure Legends.
Supplementary Tables 1 Through 4 from Mir200c Attenuates P-gp–Mediated MDR and Metastasis by Targeting JNK2/c-Jun Signaling Pathway in Colorectal Cancer

Hua Sui,Guo-Xiang Cai,Shu-Fang Pan,Wan-Li Deng,Yu-Wei Wang,Zhe-Sheng Chen,San-Jun Cai,Hui-Rong Zhu,Qi Li

DOI: https://doi.org/10.1158/1535-7163.22501848.v1

2023-01-01

Abstract:Supplementary Tables 1 through 4: Resistance to chemotherapeutic drugs in HCT8/V and HCT116/MDR cells.
Transcriptional Repression of Mir-200 Family Members by Nanog in Colon Cancer Cells Induces Epithelial Mesenchymal Transition (Emt)

Qiong Pan,Linkun Meng,Jun Ye,Xiaolong Wei,Yangyang Shang,Yin Tian,Yonghong He,Zhihong Peng,Lei Chen,Wensheng Chen,Xiuwu Bian,Rongquan Wang

DOI: https://doi.org/10.1016/j.canlet.2017.01.039

IF: 9.756

2017-01-01

Cancer Letters

Abstract:Nanog is an important embryonic stem cell (ESC) gene that does not function as a classical oncogene, but needs to cooperate with other molecules to potentiate tumorigenic activity. The question addressed by the present study was whether a miRNA link exists between Nanog and epithelial–mesenchymal transition (EMT)-mesenchymal–epithelial transition (MET) plasticity. Here, we found that Nanog mRNA expression level was inversely correlated with miR-200c and miR-200b expression levels in colon cancer cell lines and human colorectal cancer tissues. Forced Nanog expression in low-Nanog colon cancer cells inhibited miR-200c and miR-200b expression, and interfered Nanog expression in high-Nanog colon cancer cells promoted miR-200c and miR-200b expression. Furthermore, we confirmed that Nanog directly repressed transcription of the miR-200c and miR-200b genes, and miR-200c and miR-200b mediated Nanog-induced EMT occurrence. Luciferase and ChIP assays determined that Nanog bound directly to the potential Nanog binding sites in the miR-200c and miR-200b promoters and repressed their transcription. In conclusion, our findings suggest that Nanog modulates EMT–MET plasticity by regulating miR-200 clusters via a direct transcriptional mechanism, and the Nanog-miR-200 axis may be a good therapeutic target for CRC control.
miR200c attenuates P-gp-mediated MDR and metastasis by targeting JNK2/c-Jun signaling pathway in colorectal cancer

Hua Sui,Guo-Xiang Cai,Shu-Fang Pan,Wan-Li Deng,Yu-Wei Wang,Zhe-Sheng Chen,San-Jun Cai,Hui-Rong Zhu,Qi Li

DOI: https://doi.org/10.1158/1535-7163.MCT-14-0167

Abstract:MicroRNA-200c (miR200c) recently emerged as an important regulator of tumorigenicity and cancer metastasis; however, its role in regulating multidrug resistance (MDR) remains unknown. In the current study, we found that the expression levels of miR200c in recurrent and metastatic colorectal cancers were significantly lower, whereas the JNK2 expression was higher compared with primary tumors. We showed that in MDR colorectal cancer cells, miR200c targeted the 3' untranslated region of the JNK2 gene. Overexpression of miR200c attenuated the levels of p-JNK, p-c-Jun, P-gp, and MMP-2/-9, the downstream factors of the JNK signaling pathway, resulting in increased sensitivity to chemotherapeutic drugs, which was accompanied by heightened apoptosis and decreased cell invasion and migration. Moreover, in an orthotopic MDR colorectal cancer mouse model, we demonstrated that overexpression of miR200c effectively inhibited the tumor growth and metastasis. At last, in the tumor samples from patients with locally advanced colorectal cancer with routine postsurgical chemotherapy, we observed an inverse correlation between the levels of mRNA expression of miR200c and JNK2, ABCB1, and MMP-9, thus predicting patient therapeutic outcomes. In summary, we found that miR200c negatively regulated the expression of JNK2 gene and increased the sensitivity of MDR colorectal cancer cells to chemotherapeutic drugs, via inhibiting the JNK2/p-JNK/p-c-Jun/ABCB1 signaling. Restoration of miR200c expression in MDR colorectal cancer may serve as a promising therapeutic approach in MDR-induced metastasis.
MicroRNA-206 Attenuates Tumor Proliferation and Migration Involving the Downregulation of NOTCH3 in Colorectal Cancer.

Xiao-Wei Wang,Xue-Qin Xi,Jian Wu,Yi-Yuan Wan,Hong-Xia Hui,Xiu-Feng Cao

DOI: https://doi.org/10.3892/or.2015.3731

2015-01-01

Oncology Reports

Abstract:Colorectal cancer (CRC) is the most common cancer diagnosed worldwide, and the development of metastases is a major cause of mortality. Accumulating evidence suggests that microRNAs are important in carcinogenesis by affecting the expression of genes that regulate cancer progression. A number of studies have shown that miR-206 is frequently downregulated in many human malignancies, including CRC, and is associated with a more malignant phenotype. Previous studies involving HeLa and C2C12 cells have validated the inhibitory mechanism of miR-206 via NOTCH3 targeting. However, whether or not the interplay between miR-206 and NOTCH3 also occurs in CRC is unknown. Therefore, we investigated the tumor suppressive and metastatic effects of miR-206 and its target, NOTCH3, in CRC. Based on the inverse association between the expression of miR-206 and NOTCH3 in CRC tissues, miR-206 mimics were transiently transfected into the SW480 (and its metastatic strain) and SW620 colon cancer cell lines. Upregulation of miR-206 inhibited cancer cell prolife-ration and migration, blocked the cell cycle, and activated apoptosis. The tumor suppressive capacity of miR-206 had a similar effect on CRC cells, although with a different metastatic potential, and may be explained by direct NOTCH3 signaling inhibition and indirect cross-talk with other signaling pathways involving CDH2 and MMP-9. These results support miR-206 as a tumor suppressor in CRC and suggest a potential therapeutic target for clinical intervention.
Supplementary Figures 1-6 from Loss of SNAIL Regulated Mir-128-2 on Chromosome 3p22.3 Targets Multiple Stem Cell Factors to Promote Transformation of Mammary Epithelial Cells

PengXu Qian,Arindam Banerjee,Zheng-Sheng Wu,Xiao Zhang,Hong Wang,Vijay Pandey,Wei-Jie Zhang,Xue-Fei Lv,Sheng Tan,Peter E. Lobie,Tao Zhu

DOI: https://doi.org/10.1158/0008-5472.22395998

2023-01-01

Abstract:PDF file - 1291K, FIGURE S1: Representative data of genomic real-time PCR screening for DNA copy numbers of aberrant microRNAs on human chromosome 3p in breast carcinoma and the correlation between expression levels of miR-128 and ARPP21; FIGURE S2: miR-128 depletion confers non-tumorigenic MCF-10A cells with a malignant phenotype in vitro; FIGURE S3: Forced expression of miR-128 alters the morphology and reduces migration and invasion of MCF-7 cells in vitro, whereas miR-128 depletion confers non-tumorigenic HBL-100 cells with a malignant phenotype in vitro; FIGURE S4: miR-128 depletion confers a malignant phenotype on non-tumorigenic MCF-10A cells in vivo and miR-128 represses the CD44+CD24 Neg/Low population in mammary carcinoma cells; FIGURE S5: Interactions between miR-128 and its binding targets; FIGURE S6: Luciferase assay for promoter activity
1069 MicroRNA-143 is a Potential Tumor Suppressor Targeting DNA Methyltransferases 3a in Colorectal Cancer

Enders K. O. Ng,Wing Pui Tsang,Simon S. Ng,Hongchuan Jin,Jun Yu,Christoph Roecken,Matthias P. A. Ebert,Joseph J. Sung,Tim Tak Kwok

DOI: https://doi.org/10.1016/s0016-5085(09)60742-3

IF: 29.4

2009-01-01

Gastroenterology

Abstract:HCA-7 human colorectal cancer cells were transfected with miRNA precursor forms, pre-miR-143 or pre-miR-145; or c-Myc siRNA or scrambled oligonucleotides using Lipofectamine.Colon cancer cell or colonic fibroblast EGFR was activated with EGF or inhibited with C225 anti-EGFR antibodies.Western blotting was used to assess G1 cell cycle regulators: c-Myc, cdk6, cyclin D2, E2F3 and pRb.Northern blotting and real time PCR were used to measure miR-143 and miR-145.Cell proliferation and DNA synthesis were measured by WST-1 and BrdU incorporation, respectively.Results: Northern blotting confirmed low levels of miR-143 and miR-145 in human colon cancers and cell lines.As in the case of human cancers, miR-143 and miR-145 were down-regulated 90% in colonic tumors of mice with wt EGFR.In striking contrast, these miRNA were increased 4-5-fold in tumors from Wa2 Egfr mice.Wa2 mutations nearly abolish receptor kinase activity In Vitro.Up-regulations of pre-miR-143 or pre-miR-145 by transfection caused 60-70% reduction in proliferation and inhibited DNA synthesis by 80-90% in HCT116 cells, consistent with a tumor suppressor role for these miRNA.Modulating EGFR signals caused parallel changes in c-Myc, while inducing inverse changes in miR-143 and miR-145 in cancer cells (C225-treated) and fibroblasts (EGF-treated).c-Myc siRNA knock-down also increased miR-143 and miR-145 by 50-95% in cancer cells, while decreasing c-Myc ~90%, suggesting c-Myc mediates EGFR suppression of these miRNAs.Compared to control, EGF increased cdk6, pRb and E2F3, whereas C225 antibodies reduced these proteins in cancer cells, identifying these G1 regulators as EGFR targets.In contrast, pre-miR-143 and pre-miR-145 reduced these G1 regulators by 30-60% in HCT116 cells, suggesting they are also functional targets of miR-143 and miR-145.Conclusion: These studies suggest that EGFR proliferation is mediated by c-Myc via inhibition of miR-143 and miR-145.Furthermore, we have demonstrated for the first time that these miRNA negatively control G1 cell cycle regulators.
Mir-139-5p Inhibits the Epithelial-Mesenchymal Transition and Enhances the Chemotherapeutic Sensitivity of Colorectal Cancer Cells by Downregulating BCL2

Qingguo Li,Xin Liang,Yuwei Wang,Xianke Meng,Ye Xu,Sanjun Cai,Zhimin Wang,Jianwen Liu,Guoxiang Cai

DOI: https://doi.org/10.1038/srep27157

IF: 4.6

2016-01-01

Scientific Reports

Abstract:MicroRNAs (miRNAs) are important regulators involved in various cancers, including colorectal cancer (CRC). The functions and mechanisms of the miRNAs involved in CRC progress and metastasis are largely unknown. In this study, miRNA microarray analysis was performed to screen crucial miRNAs involved in CRC progress, and miR-139-5p was chosen for further study. The functional roles of miR-139-5p in colon cancer were demonstrated by CCK-8 proliferation assay, cell invasion and migration, cell apoptosis and in a KO mouse study. miR-139-5p expression was significantly decreased in cancer tissues compared to normal tissues. The miR-139-5p expression level was associated with tumour stage (P < 0.01). Function studies revealed that miR-139-5p was significantly correlated with the metastasis potential and drug resistance of colon cancer cells by affecting the epithelial-mesenchymal transition (EMT). Then, we identified BCL2 as a direct target of miR-139-5p cells in vitro. The patient samples and KO mice model showed that BCL2 expression was inversely correlated with the expression of miR-139-5p. In conclusion, we found that miR-139-5p targeted the BCL2 pathway to reduce tumour metastasis and drug sensitivity in CRC. This axis provided insight into the mechanism underlying miRNA regulation of CRC metastasis and a novel therapeutic target for CRC therapy.
Supplementary Figure S1-S9 from Silencing of Long Noncoding RNA MIR22HG Triggers Cell Survival/Death Signaling Via Oncogenes YBX1, MET, and P21 in Lung Cancer

Wenmei Su,Shumei Feng,Xiuyuan Chen,Xia Yang,Rui Mao,Chunfang Guo,Zhuwen Wang,Dafydd G. Thomas,Jules Lin,Rishindra M. Reddy,Mark B. Orringer,Andrew C. Chang,Zhixiong Yang,David G. Beer,Guoan Chen

DOI: https://doi.org/10.1158/0008-5472.22419857.v1

2023-01-01

Abstract:Supplementary Figures S1-S9. S1: MIR22HG expression in lung cancer. S2: MIR22HG expression in lung cancer cell lines. S3: Changing of cell proliferation, colony formation, migration and invasion after MIR22HG knockdown in lung cancers. S4: Western blot showing the changing of AKT, ERK1/2 and STAT3 proteins after MIR22HG siRNA treatment. S5: MIR22HG interacts with YBX1 protein and the correlation of MIR22HG, MET, YBX1 and p21. S6: P21 plays an oncogenic role in promoting tumor cell proliferation, anti-apoptosis and senescence. S7: Genes negatively correlated to MIR22HG are involved in cell cycle/proliferation regulation in primary lung cancer. S8: MIR22HG, CDKN1A (p21), YBX1 and MET mRNA expression in primary tumors and correlation on different lung RNA-seq datasets. S9: Higher expression of p21 mRNA Is related to poor patient survival and p21 protein is co-expressed with Ki-67 in a subset of tumors.
Changes in the Expression of Mir-381 and Mir-495 Are Inversely Associated with the Expression of the MDR1 Gene and Development of Multi-Drug Resistance

Yan Xu,Stephen J. Ohms,Zhen Li,Qiao Wang,Guangming Gong,Yiqiao Hu,Zhiyong Mao,M. Frances Shannon,Jun Y. Fan

DOI: https://doi.org/10.1371/journal.pone.0082062

IF: 3.7

2013-01-01

PLoS ONE

Abstract:Multidrug resistance (MDR) frequently develops in cancer patients exposed to chemotherapeutic agents and is usually brought about by over-expression of P-glycoprotein (P-gp) which acts as a drug efflux pump to reduce the intracellular concentration of the drug(s). Thus, inhibiting P-gp expression might assist in overcoming MDR in cancer chemotherapy. MiRNAome profiling using next-generation sequencing identified differentially expressed microRNAs (miRs) between parental K562 cells and MDR K562 cells (K562/ADM) induced by adriamycin treatment. Two miRs, miR-381 and miR-495, that were strongly down-regulated in K562/ADM cells, are validated to target the 3’-UTR of the MDR1 gene. These miRs are located within a miR cluster located at chromosome region 14q32.31, and all miRs in this cluster appear to be down-regulated in K562/ADM cells. Functional analysis indicated that restoring expression of miR-381 or miR-495 in K562/ADM cells was correlated with reduced expression of the MDR1 gene and its protein product, P-gp, and increased drug uptake by the cells. Thus, we have demonstrated that changing the levels of certain miR species modulates the MDR phenotype in leukemia cells, and propose further exploration of the use of miR-based therapies to overcome MDR.
Supplementary Figure 1 from DNA Methylation-Mediated Repression of Mir-886-3p Predicts Poor Outcome of Human Small Cell Lung Cancer

Jianzhong Cao,Yongmei Song,Nan Bi,Jie Shen,Wenyang Liu,Jing Fan,Guogui Sun,Tong,Jie He,Yuankai Shi,Xun Zhang,Ning Lu,Yinghua He,Hongyu Zhang,Kelong Ma,Xiaoying Luo,Lei Lv,Hui Deng,Jing Cheng,Jingde Zhu,Luhua Wang,Qimin Zhan

DOI: https://doi.org/10.1158/0008-5472.22397222

2023-01-01

Abstract:PDF file - 129K, Kaplan-Meier analyses for progression free survival (PFS) and distant metastasis free survival (DMFS) between the low and high miR-886-3p expressing groups.
Supplementary Figures S1-S6 from Cytidine Deaminase Axis Modulated by Mir-484 Differentially Regulates Cell Proliferation and Chemoresistance in Breast Cancer

Fu-Gui Ye,Chuan-Gui Song,Zhi-Gang Cao,Chen Xia,Dan-Na Chen,Li Chen,Shan Li,Feng Qiao,Hong Ling,Ling Yao,Xin Hu,Zhi-Ming Shao

DOI: https://doi.org/10.1158/0008-5472.22406627

2023-01-01

Abstract:Supplementary Figures S1-S6: qPCR analysis of selected genes was performed in MDA-231-Gem and parental MDA-231 cells (S1); qPCR analysis of 7 genes in the gemcitabine metabolism pathway was performed in MDA-231-Gem and parental MDA-231 cells (S2); The expression of miR-339-5p, miR-484 and miR-345-5p was assessed by miRNA qPCR in MDA-231-Gem cells compared to MDA-231 cells (S3); Constructing an mRNA-miRNA network associated with the gemcitabine metabolism pathway (S4); Patient cohorts for IHC analysis (S5); Patient cohort for mRNA and miRNA expression analyses (S6).
Mir-204-5p Inhibits Proliferation and Invasion and Enhances Chemotherapeutic Sensitivity of Colorectal Cancer Cells by Downregulating RAB22A.

Yuan Yin,Binbin Zhang,Weili Wang,Bojian Fei,Chao Quan,Jiwei Zhang,Mingxu Song,Zehua Bian,Qifeng Wang,Shujuan Ni,Yaling Hu,Yong Mao,Leyuan Zhou,Yugang Wang,Jian Yu,Xiang Du,Dong Hua,Zhaohui Huang

DOI: https://doi.org/10.1158/1078-0432.ccr-14-1030

IF: 13.801

2014-01-01

Clinical Cancer Research

Abstract:Abstract Purpose: miR-204-5p was found to be downregulated in colorectal cancer tissues in our preliminary microarray analyses. However, the function of miR-204-5p in colorectal cancer remains unknown. We therefore investigated the role, mechanism, and clinical significance of miR-204-5p in colorectal cancer development and progression. Experimental Design: We measured the expression of miR-204-5p and determined its correlation with patient prognoses. Ectopic expression in colorectal cancer cells, xenografts, and pulmonary metastasis models was used to evaluate the effects of miR-204-5p on proliferation, migration, and chemotherapy sensitivity. Luciferase assay and Western blotting were performed to validate the potential targets of miR-204-5p after the preliminary screening by a microarray analysis and computer-aided algorithms. Results: miR-204-5p is frequently downregulated in colorectal cancer tissues, and survival analysis showed that the downregulation of miR-204-5p in colorectal cancer was associated with poor prognoses. Ectopic miR-204-5p expression repressed colorectal cancer cell growth both in vitro and in vivo. Moreover, restoring miR-204-5p expression inhibited colorectal cancer migration and invasion and promoted tumor sensitivity to chemotherapy. Mechanistic investigations revealed that RAB22A, a member of the RAS oncogene family, is a direct functional target of miR-204-5p in colorectal cancer. Furthermore, RAB22A protein levels in colorectal cancer tissues were frequently increased and negatively associated with miR-204-5p levels and survival time. Conclusions: Our results demonstrate for the first time that miR-204-5p acts as a tumor suppressor in colorectal cancer through inhibiting RAB22A and reveal RAB22A to be a new oncogene and prognostic factor for colorectal cancer. Clin Cancer Res; 20(23); 6187–99. ©2014 AACR.
Mir-200Bc/429 Cluster Modulates Multidrug Resistance of Human Cancer Cell Lines by Targeting BCL2 and XIAP.

Wei Zhu,Huaguo Xu,DanXia Zhu,Hui Zhi,Tongshan Wang,Jian Wang,Binghua Jiang,Yongqian Shu,Ping Liu

DOI: https://doi.org/10.1007/s00280-011-1752-3

2011-01-01

Cancer Chemotherapy and Pharmacology

Abstract:PURPOSE:MicroRNAs (miRNAs) are short non-coding RNA molecules, which post-transcriptionally regulate genes expression and play crucial roles in diverse biological processes. Recent studies have shown that dysregulation of miRNAs might modulate the resistance of cancer cells to anti-cancer drugs, yet the modulation mechanism is not fully understood. We aimed to investigate the possible role of miRNAs in the development of multidrug resistance (MDR) in human gastric and lung cancer cell lines.METHODS:miRNA Quantitative real-time PCR was used to detect the different miRNA expression levels between drug resistant and parental cancer cells. MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay was used to test the drug-resistant phenotype changes in cancer cells via over or downregulation of miRNAs. Dual-luciferase activity assay was used to verify the target genes of miRNAs. Western blot analysis and apoptosis assay were used to elucidate the mechanism of miRNAs on modulating drug resistance in cancer cells.RESULTS:miR-200bc/429 cluster was downregulated, while BCL2 and XIAP were upregulated in both MDR SGC7901/VCR (vincristine) and A549/CDDP (cisplatin) cells, compared with the parental SGC7901 and A549 cells, respectively. Overexpression of miR-200bc/429 cluster sensitized SGC7901/VCR and A549/CDDP cells to anti-cancer drugs, respectively. Both BCL2 and XIAP 3'-UTR reporters constructed in MDR cells suggested that BCL2 and XIAP were the common target genes of the miR-200bc/429 cluster. Enforced miR-200bc/429 cluster expression reduced BCL2 and XIAP protein level and sensitized both MDR cells to VCR-induced and CDDP-induced apoptosis, respectively.CONCLUSIONS:Our findings first suggest that miR-200bc/429 cluster could play a role in the development of MDR in both gastric and lung cancer cell lines, at least in part by modulation of apoptosis via targeting BCL2 and XIAP.
Supplementary Figures from Mir-508 Defines the Stem-like/Mesenchymal Subtype in Colorectal Cancer

Ting-Ting Yan,Lin-Lin Ren,Chao-Qin Shen,Zhen-Hua Wang,Ya-Nan Yu,Qian Liang,Jia-Yin Tang,Ying-Xuan Chen,Dan-Feng Sun,Witold Zgodzinski,Marek Majewski,Piotr Radwan,Ilona Kryczek,Ming Zhong,Jinxian Chen,Qiang Liu,Weiping Zou,Hao-Yan Chen,Jie Hong,Jing-Yuan Fang

DOI: https://doi.org/10.1158/0008-5472.22417238

2023-01-01

Abstract:This file contains supplementary figures 1-7 and the main information was described as follows. Fig. S1. Differential microRNA and mRNA profiles in the stem-like/EMT subtype of CRC in TCGA. Fig. S2. Role of miR-506 family in the control of the stem-like/EMT subtype of CRC. Fig. S3. Target genes and role of miR-508 in CRC stem/EMT-signal activation. Fig. S4. Associations of miR-508 expression with the stem-like/EMT and stromal genes in CRC. Fig. S5. Involvement of miR-508 in the regulation of TGFβ-mediated EMT in CRC. Fig. S6. Association between miR-508 and survival in CRC. Fig. S7. Involvement of hypoxia and AK000053 lncRNA in the downregulation of miR-508 and the miR-508-mediated target gene in CRC.
Mir-338-3p Suppresses Colorectal Cancer Proliferation and Progression by Inhibiting MACC1.

Teng Zou,Jing Duan,Jiangtao Liang,Huijuan Shi,Tiantian Zhen,Hui Li,Fenfen Zhang,Yu Dong,Anjia Han

2018-01-01

Abstract:Colorectal cancer (CRC) is one of the most common malignancies worldwide. This study aimed to elucidate the clinicopathological significance of miR-338-3p and its association with metastasis-associated in colon cancer-1 (MACC1) in CRC. We evaluated miR-338-3p and MACC1 expression in CRC cell lines and analyzed the clinicopathological features of miR-338-3p in 98 samples of CRC tissues. Subsequent Western blot and cellular biological techniques, and xenograft mouse models were performed to investigate the biological role of miR-338-3p and its association with MACC1 in CRC. Our results show that miR-338-3p expression is lower in CRC cell lines and tissues than that in a human normal colonic epithelial cell line and adjacent normal colorectal tissue, respectively. miR-338-3p expression was significantly associated with histological differentiation, UICC stage, T classification, N classification, and M classification in 98 samples of CRC. The overall survival of CRC patients was significantly less in the low miR-338-3p expression group than in the high miR-338-3p expression group (p<0.01). miR-338-3p mimics suppressed cell proliferation, colony formation, migration, and invasion, but induced apoptosis in CRC cells. miR-338-3p inhibitor reversed these biological phenotypes. miR-338-3p mimics or inhibitor suppressed or increased MACC1 expression in HCT116 and SW620. miR-338-3p mimics reversed the effect of increased MACC1 expression induced by HCT116 with MACC1 over-expression plasmid. Increased cell proliferation, colony formation, and suppressed cell apoptosis caused by MACC1 over-expression were significantly reversed in HCT116 transfected with miR-338-3p mimics, respectively. Suppressed cell proliferation, colony formation, migration, invasion, and increased cell apoptosis caused by MACC1 knockdown were significantly reversed in SW620 transfected with miR-338-3p inhibitor, respectively. In vivo, miR-338-3p agomir significantly inhibited xenograft CRC tumor growth and reversed the effect of increased xenograft tumor growth induced from HCT116 with MACC1 overexpression. In conclusion, our data suggest that miR-338-3p suppresses CRC carcinogenesis and progression by inhibiting MACC1. Targeting miR-338-3p might be a novel treatment strategy for CRC.
Supplementary Figure 4 from DNA Methylation-Mediated Repression of Mir-886-3p Predicts Poor Outcome of Human Small Cell Lung Cancer

Jianzhong Cao,Yongmei Song,Nan Bi,Jie Shen,Wenyang Liu,Jing Fan,Guogui Sun,Tong,Jie He,Yuankai Shi,Xun Zhang,Ning Lu,Yinghua He,Hongyu Zhang,Kelong Ma,Xiaoying Luo,Lei Lv,Hui Deng,Jing Cheng,Jingde Zhu,Luhua Wang,Qimin Zhan

DOI: https://doi.org/10.1158/0008-5472.22397213.v1

2023-01-01

Abstract:PDF file - 152K, Forced expression of PLK1 and TGF-β1 reversed the phenotype created by Mimic transfection in NCI-H446 cells.
Supplementary Data from Long Noncoding RNA MIR17HG Promotes Colorectal Cancer Progression via miR-17-5p

Jie Xu,Qingtao Meng,Xiaobo Li,Hongbao Yang,Jin Xu,Na Gao,Hao Sun,Shenshen Wu,Giuseppe Familiari,Michela Relucenti,Haitao Zhu,Jiong Wu,Rui Chen

DOI: https://doi.org/10.1158/0008-5472.22420728.v1

2023-01-01

Abstract:This file contains supplemental materials and methods, supplemental tables: ST1 Demographic characteristics of CRC patients recruited for microarray assay, ST2: Distributions of demographic and clinicopathologic characteristics of patients recruited for TMA; ST3: Demographic information of colorectal adenoma (ADE) patients for PCR analysis; ST4:Demographic information of colorectal cancer (CRC) patients for PCR analysis; supplemental figures SF1:Construction of an immunity-associated network involved in CRC progression; SF2:Roles of RELA and MIR17HG in murine AOM-DSS models and CRC cohorts; SF3:miR-17-5p promotes CRC tumorigenesis; SF4: MIR17HG promotes CRC tumorigenesis through suppressing BLNK; SF5: MIR17HG promotes CRC tumorigenesis through binding to miR-17-3p in vitro and in vivo; SF6: Regulation of MALT1, NFKBIE, PPP3R1 and MAP3K7 by miR-17-3p in CRC; SF7: Expression levels of PD-L1 mRNA in cells; SF8: Expression levels of PD-L1 protein in tumor tissues

Supplementary Figure 1 from Mir200c Attenuates P-gp–Mediated MDR and Metastasis by Targeting JNK2/c-Jun Signaling Pathway in Colorectal Cancer

Supplementary Figure 3 from Mir200c Attenuates P-gp–Mediated MDR and Metastasis by Targeting JNK2/c-Jun Signaling Pathway in Colorectal Cancer

Data from Mir200c Attenuates P-gp–Mediated MDR and Metastasis by Targeting JNK2/c-Jun Signaling Pathway in Colorectal Cancer

Supplementary Materials and Methods and Supplementary Figure Legends from Mir200c Attenuates P-gp–Mediated MDR and Metastasis by Targeting JNK2/c-Jun Signaling Pathway in Colorectal Cancer

Supplementary Tables 1 Through 4 from Mir200c Attenuates P-gp–Mediated MDR and Metastasis by Targeting JNK2/c-Jun Signaling Pathway in Colorectal Cancer

Transcriptional Repression of Mir-200 Family Members by Nanog in Colon Cancer Cells Induces Epithelial Mesenchymal Transition (Emt)

miR200c attenuates P-gp-mediated MDR and metastasis by targeting JNK2/c-Jun signaling pathway in colorectal cancer

MicroRNA-206 Attenuates Tumor Proliferation and Migration Involving the Downregulation of NOTCH3 in Colorectal Cancer.

Supplementary Figures 1-6 from Loss of SNAIL Regulated Mir-128-2 on Chromosome 3p22.3 Targets Multiple Stem Cell Factors to Promote Transformation of Mammary Epithelial Cells

1069 MicroRNA-143 is a Potential Tumor Suppressor Targeting DNA Methyltransferases 3a in Colorectal Cancer

Mir-139-5p Inhibits the Epithelial-Mesenchymal Transition and Enhances the Chemotherapeutic Sensitivity of Colorectal Cancer Cells by Downregulating BCL2

Supplementary Figure S1-S9 from Silencing of Long Noncoding RNA MIR22HG Triggers Cell Survival/Death Signaling Via Oncogenes YBX1, MET, and P21 in Lung Cancer

Changes in the Expression of Mir-381 and Mir-495 Are Inversely Associated with the Expression of the MDR1 Gene and Development of Multi-Drug Resistance

Supplementary Figure 1 from DNA Methylation-Mediated Repression of Mir-886-3p Predicts Poor Outcome of Human Small Cell Lung Cancer

Supplementary Figures S1-S6 from Cytidine Deaminase Axis Modulated by Mir-484 Differentially Regulates Cell Proliferation and Chemoresistance in Breast Cancer

Mir-204-5p Inhibits Proliferation and Invasion and Enhances Chemotherapeutic Sensitivity of Colorectal Cancer Cells by Downregulating RAB22A.

Mir-200Bc/429 Cluster Modulates Multidrug Resistance of Human Cancer Cell Lines by Targeting BCL2 and XIAP.

Supplementary Figures from Mir-508 Defines the Stem-like/Mesenchymal Subtype in Colorectal Cancer

Mir-338-3p Suppresses Colorectal Cancer Proliferation and Progression by Inhibiting MACC1.

Supplementary Figure 4 from DNA Methylation-Mediated Repression of Mir-886-3p Predicts Poor Outcome of Human Small Cell Lung Cancer

Supplementary Data from Long Noncoding RNA MIR17HG Promotes Colorectal Cancer Progression via miR-17-5p